Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 458

1.

Biopsy-diagnosed renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma: a case series and review of the literature.

Narita K, Akita H, Kikuchi E, Nakahara T, Okuda S, Nakatsuka S, Oya M, Jinzaki M.

BJR Case Rep. 2019 Nov 15;5(4). pii: bjrcr.20190012. doi: 10.1259/bjrcr.20190012. eCollection 2019 Dec.

2.

Clinically useful limited sampling strategy to estimate area under the concentration-time curve of once-daily tacrolimus in adult Japanese kidney transplant recipients.

Nakazawa R, Yoshiike M, Nozawa S, Aida K, Katsuoka Y, Fujimoto E, Yazawa M, Kikuchi E, Shibagaki Y, Sasaki H.

PLoS One. 2019 Dec 11;14(12):e0225878. doi: 10.1371/journal.pone.0225878. eCollection 2019.

3.

Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer: Its definition and future therapeutic strategies.

Kikuchi E, Hayakawa N, Fukumoto K, Shigeta K, Matsumoto K.

Int J Urol. 2019 Dec 3. doi: 10.1111/iju.14153. [Epub ahead of print] Review.

PMID:
31793703
4.
5.

A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302).

Asahina H, Oizumi S, Takamura K, Harada T, Harada M, Yokouchi H, Kanazawa K, Fujita Y, Kojima T, Sugaya F, Tanaka H, Honda R, Kikuchi E, Ikari T, Ogi T, Shimizu K, Suzuki M, Konno S, Dosaka-Akita H, Isobe H, Nishimura M; Hokkaido Lung Cancer Clinical Study Group.

Lung Cancer. 2019 Dec;138:65-71. doi: 10.1016/j.lungcan.2019.09.020. Epub 2019 Sep 30.

PMID:
31654836
6.

The efficacy of the TachoSil binding suturing technique in laparoscopic partial nephrectomy to prevent the development of pseudoaneurysm.

Shigeta K, Matsumoto K, Abe T, Komatsuda A, Takeda T, Mizuno R, Kikuchi E, Asanuma H, Arita Y, Akita H, Jinzaki M, Miyajima A, Oya M.

Asian J Surg. 2019 Oct 16. pii: S1015-9584(19)30793-6. doi: 10.1016/j.asjsur.2019.09.002. [Epub ahead of print]

7.

Spatio-temporal stable isotope variation of a benthic primary consumer in a simple food web in a strongly acidic lake.

Doi H, Kikuchi E, Takagi S, Shikano S.

PeerJ. 2019 Oct 11;7:e7890. doi: 10.7717/peerj.7890. eCollection 2019.

8.

Differences in the occupational therapy goals of clients and therapists affect the outcomes of patients in subacute rehabilitation wards: a case-control study.

Saito Y, Tomori K, Nagayama H, Sawadai T, Kikuchi E.

J Phys Ther Sci. 2019 Jul;31(7):521-525. doi: 10.1589/jpts.31.521. Epub 2019 Jul 2.

9.

A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.

Shigeta K, Kikuchi E, Abe T, Hagiwara M, Ogihara K, Anno T, Umeda K, Baba Y, Sanjo T, Shojo K, Mikami S, Mizuno R, Oya M.

Eur Urol Oncol. 2019 Aug 5. pii: S2588-9311(19)30102-6. doi: 10.1016/j.euo.2019.06.021. [Epub ahead of print]

PMID:
31395480
10.

Long-Term Oncologic Outcomes of Laparoscopic Versus Open Radical Nephroureterectomy for Patients with T3N0M0 Upper Tract Urothelial Carcinoma: A Multicenter Cohort Study with Adjustment by Propensity Score Matching.

Shigeta K, Kikuchi E, Abe T, Hagiwara M, Ogihara K, Anno T, Umeda K, Baba Y, Sanjo T, Shojo K, Mizuno R, Oya M.

Ann Surg Oncol. 2019 Oct;26(11):3774-3781. doi: 10.1245/s10434-019-07623-1. Epub 2019 Jul 16.

PMID:
31313043
11.

CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC.

Becker JH, Gao Y, Soucheray M, Pulido I, Kikuchi E, Rodríguez ML, Gandhi R, Lafuente-Sanchis A, Aupí M, Alcácer Fernández-Coronado J, Martín-Martorell P, Cremades A, Galbis-Caravajal JM, Alcácer J, Christensen CL, Simms P, Hess A, Asahina H, Kahle MP, Al-Shahrour F, Borgia JA, Lahoz A, Insa A, Juan O, Jänne PA, Wong KK, Carretero J, Shimamura T.

Cancer Res. 2019 Sep 1;79(17):4439-4452. doi: 10.1158/0008-5472.CAN-19-0024. Epub 2019 Jul 4.

PMID:
31273063
12.

TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells.

Niwa N, Tanaka N, Hongo H, Miyazaki Y, Takamatsu K, Mizuno R, Kikuchi E, Mikami S, Kosaka T, Oya M.

Lab Invest. 2019 Nov;99(11):1702-1713. doi: 10.1038/s41374-019-0285-y. Epub 2019 Jul 1.

PMID:
31263157
13.

Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses.

Ohyama C, Kojima T, Kondo T, Naya Y, Inoue T, Tomita Y, Eto M, Hisasue S, Uemura H, Obara W, Kikuchi E, Sharma P, Galsky MD, Siefker-Radtke A, Grossfeld G, Collette S, Gooden K, Kimura G.

Int J Clin Oncol. 2019 Sep;24(9):1089-1098. doi: 10.1007/s10147-019-01450-w. Epub 2019 Jun 19.

PMID:
31218529
14.

Bromodomain and extraterminal domain inhibition synergizes with WEE1-inhibitor AZD1775 effect by impairing nonhomologous end joining and enhancing DNA damage in nonsmall cell lung cancer.

Takashima Y, Kikuchi E, Kikuchi J, Suzuki M, Kikuchi H, Maeda M, Shoji T, Furuta M, Kinoshita I, Dosaka-Akita H, Sakakibara-Konishi J, Konno S.

Int J Cancer. 2020 Feb 15;146(4):1114-1124. doi: 10.1002/ijc.32515. Epub 2019 Jun 28.

PMID:
31199520
15.

Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations.

Ikari T, Sakakibara-Konishi J, Yamamoto G, Kitai H, Mizugaki H, Asahina H, Kikuchi E, Shinagawa N.

Clin Lung Cancer. 2019 Jul;20(4):e531-e533. doi: 10.1016/j.cllc.2019.05.002. Epub 2019 May 11. No abstract available.

PMID:
31164318
16.

Preserved Kidney Volume, Body Mass Index, and Age Are Significant Preoperative Factors for Predicting Estimated Glomerular Filtration Rate in Living Kidney Donors at 1 Year After Donation.

Shinoda K, Morita S, Akita H, Washizuka F, Tamaki S, Takahashi R, Oguchi H, Sakurabayashi K, Mizutani T, Takahashi Y, Hyodo Y, Itabashi Y, Muramatsu M, Kawamura T, Asanuma H, Kikuchi E, Jinzaki M, Shiraga N, Nakagawa K, Oya M, Shishido S, Sakai K.

Transplant Proc. 2019 Jun;51(5):1306-1310. doi: 10.1016/j.transproceed.2019.01.142. Epub 2019 May 7.

PMID:
31076152
17.

Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients.

Takamatsu K, Mizuno R, Tanaka N, Takeda T, Morita S, Matsumoto K, Kosaka T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Int J Clin Oncol. 2019 Sep;24(9):1069-1074. doi: 10.1007/s10147-019-01459-1. Epub 2019 May 7.

PMID:
31065836
18.

Response of BRAFV600E-Mutant Lung Adenocarcinoma With Brain Metastasis and Leptomeningeal Dissemination to Dabrafenib Plus Trametinib Treatment.

Yamamoto G, Sakakibara-Konishi J, Ikari T, Kitai H, Mizugaki H, Asahina H, Kikuchi E, Shinagawa N.

J Thorac Oncol. 2019 May;14(5):e97-e99. doi: 10.1016/j.jtho.2018.12.027. No abstract available.

PMID:
31027751
19.

The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.

Takamatsu K, Matsumoto K, Shojo K, Tanaka N, Takeda T, Morita S, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M.

Urol Oncol. 2019 Sep;37(9):575.e19-575.e25. doi: 10.1016/j.urolonc.2019.03.012. Epub 2019 Apr 6.

PMID:
30967332
20.

Safer Vitrification of Mouse and Human Embryos Using the Novel Cryoroom Vitrification System for Assisted Reproductive Technology.

Inui H, Mizuno J, Kikuchi E, Noguchi K, Tanji Y, Hamabata M, Kotsuzumi C, Komiyama M, Noguchi Y, Tamura M.

Cryo Letters. 2019 Jan/Feb;40(1):1-10.

PMID:
30955025
21.

Uric acid, ferritin and γ-glutamyltransferase can be informative in prediction of the oxidative stress.

Oda K, Kikuchi E, Kuroda E, Yamada C, Okuno C, Urata N, Kishimoto N, Kubo A, Ishii N, Nishizaki Y.

J Clin Biochem Nutr. 2019 Mar;64(2):124-128. doi: 10.3164/jcbn.18-23. Epub 2019 Jan 16.

22.

Editorial Comment.

Kikuchi E, Mizuno R.

J Urol. 2019 Jun;201(6):1104. doi: 10.1097/01.JU.0000554682.07201.49. No abstract available.

PMID:
30920342
23.

DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail.

Furuta M, Kikuchi H, Shoji T, Takashima Y, Kikuchi E, Kikuchi J, Kinoshita I, Dosaka-Akita H, Sakakibara-Konishi J.

Cancer Sci. 2019 May;110(5):1599-1608. doi: 10.1111/cas.13997. Epub 2019 Apr 13.

24.

Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.

Shigeta K, Kosaka T, Hongo H, Yanai Y, Matsumoto K, Morita S, Mizuno R, Shinojima T, Kikuchi E, Oya M.

Int J Clin Oncol. 2019 May;24(5):554-556. doi: 10.1007/s10147-019-01395-0.

PMID:
30826960
25.

Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.

Matsumoto K, Akita H, Narita K, Hashiguchi A, Takamatsu K, Takeda T, Kosaka T, Mizuno R, Kikuchi E, Oya M, Jinzaki M.

Prostate Cancer Prostatic Dis. 2019 Dec;22(4):539-545. doi: 10.1038/s41391-019-0136-3. Epub 2019 Feb 27.

PMID:
30814680
26.

Pre-donation BMI and preserved kidney volume can predict the cohort with unfavorable renal functional compensation at 1-year after kidney donation.

Shinoda K, Morita S, Akita H, Tamaki S, Takahashi R, Kono H, Asanuma H, Kikuchi E, Jinzaki M, Nakagawa K, Oya M.

BMC Nephrol. 2019 Feb 8;20(1):46. doi: 10.1186/s12882-019-1242-0.

27.

Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.

Ogihara K, Kikuchi E, Okazaki S, Hagiwara M, Takeda T, Matsumoto K, Kosaka T, Mikami S, Saya H, Oya M.

Cancer Sci. 2019 Apr;110(4):1431-1441. doi: 10.1111/cas.13960. Epub 2019 Mar 1.

28.

Signaling Incentive and Drive in the Primate Ventral Pallidum for Motivational Control of Goal-Directed Action.

Fujimoto A, Hori Y, Nagai Y, Kikuchi E, Oyama K, Suhara T, Minamimoto T.

J Neurosci. 2019 Mar 6;39(10):1793-1804. doi: 10.1523/JNEUROSCI.2399-18.2018. Epub 2019 Jan 9.

29.

Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.

Shigeta K, Kosaka T, Hongo H, Yanai Y, Matsumoto K, Morita S, Mizuno R, Shinojima T, Kikuchi E, Oya M.

Int J Clin Oncol. 2019 May;24(5):546-553. doi: 10.1007/s10147-018-01388-5. Epub 2019 Jan 2. Erratum in: Int J Clin Oncol. 2019 Mar 2;:.

PMID:
30604159
30.

Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells.

Tamori S, Nozaki Y, Motomura H, Nakane H, Katayama R, Onaga C, Kikuchi E, Shimada N, Suzuki Y, Noike M, Hara Y, Sato K, Sato T, Yamamoto K, Hanawa T, Imai M, Abe R, Yoshimori A, Takasawa R, Tanuma SI, Akimoto K.

Oncotarget. 2018 Nov 23;9(92):36515-36529. doi: 10.18632/oncotarget.26369. eCollection 2018 Nov 23.

31.

Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA.

Yanai Y, Kosaka T, Hongo H, Matsumoto K, Shinojima T, Kikuchi E, Miyajima A, Mizuno R, Mikami S, Jinzaki M, Oya M.

Mol Clin Oncol. 2018 Dec;9(6):656-660. doi: 10.3892/mco.2018.1725. Epub 2018 Sep 19.

32.

Immunoglobulin G4-Related Disease Arising from the Bladder Wall.

Kufukihara R, Niwa N, Mizuno R, Ohara K, Mikami S, Kikuchi E, Oya M.

Urol Int. 2019;103(4):488-490. doi: 10.1159/000495570. Epub 2018 Dec 13.

PMID:
30544121
33.

Is transperitoneal laparoscopic radical nephrectomy suitable for patients with a history of abdominal surgery?

Yanai Y, Takeda T, Miyajima A, Matsumoto K, Hagiwara M, Mizuno R, Kikuchi E, Asanuma H, Oya M.

Asian J Endosc Surg. 2019 Oct;12(4):429-433. doi: 10.1111/ases.12673. Epub 2018 Dec 2.

PMID:
30506839
34.

Long-Term Memory Engram Cells Are Established by c-Fos/CREB Transcriptional Cycling.

Miyashita T, Kikuchi E, Horiuchi J, Saitoe M.

Cell Rep. 2018 Dec 4;25(10):2716-2728.e3. doi: 10.1016/j.celrep.2018.11.022.

35.

Single-cell RNA-seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63.

Tanaka N, Katayama S, Reddy A, Nishimura K, Niwa N, Hongo H, Ogihara K, Kosaka T, Mizuno R, Kikuchi E, Mikami S, Miyakawa A, Arenas E, Kere J, Oya M, Uhlén P.

Cancer Med. 2018 Dec;7(12):6193-6204. doi: 10.1002/cam4.1828. Epub 2018 Oct 26.

36.

ASO Author Reflections: PD-1 Expression in Bacillus Calmette-Guérin-Relapsing Bladder Cancer.

Fukumoto K, Kikuchi E.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):982-983. doi: 10.1245/s10434-018-6949-9. Epub 2018 Oct 26. No abstract available.

PMID:
30367304
37.

Ureteral pseudodiverticulosis accompanied by urothelial carcinoma diagnosed by CT urography: a case report and review of the literature.

Sugiura H, Akita H, Kikuchi E, Mikami S, Hayakawa N, Narita K, Jinzaki M.

BJR Case Rep. 2018 Jan 18;4(2):20170111. doi: 10.1259/bjrcr.20170111. eCollection 2018.

38.

No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer.

Kosaka T, Hongo H, Watanabe K, Mizuno R, Kikuchi E, Oya M.

Cancer Chemother Pharmacol. 2018 Dec;82(6):1061-1066. doi: 10.1007/s00280-018-3698-1. Epub 2018 Oct 3.

39.

Performance of diffusion-weighted MRI post-CT urography for the diagnosis of upper tract urothelial carcinoma: Comparison with selective urine cytology sampling.

Akita H, Kikuchi E, Hayakawa N, Mikami S, Sugiura H, Oya M, Jinzaki M.

Clin Imaging. 2018 Nov - Dec;52:208-215. doi: 10.1016/j.clinimag.2018.08.012. Epub 2018 Aug 16.

PMID:
30125847
40.

Numb has distinct function in lung adenocarcinoma and squamous cell carcinoma.

Kikuchi H, Sakakibara-Konishi J, Furuta M, Kikuchi E, Kikuchi J, Oizumi S, Hida Y, Kaga K, Kinoshita I, Dosaka-Akita H, Nishimura M.

Oncotarget. 2018 Jun 29;9(50):29379-29391. doi: 10.18632/oncotarget.25585. eCollection 2018 Jun 29.

41.

PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer.

Yasumizu Y, Hongo H, Kosaka T, Mikami S, Nishimoto K, Kikuchi E, Oya M.

Oncotarget. 2018 Jun 12;9(45):27698-27707. doi: 10.18632/oncotarget.25498. eCollection 2018 Jun 12.

42.

History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.

Kayama E, Kikuchi E, Fukumoto K, Shirotake S, Miyazaki Y, Hakozaki K, Kaneko G, Yoshimine S, Tanaka N, Takahiro M, Kanai K, Oyama M, Nakajima Y, Hara S, Monma T, Oya M.

Clin Genitourin Cancer. 2018 Oct;16(5):e969-e976. doi: 10.1016/j.clgc.2018.04.004. Epub 2018 Apr 28.

PMID:
29778322
43.

Establishment of the optimal follow-up schedule after radical prostatectomy.

Matsumoto K, Niwa N, Hattori S, Takeda T, Morita S, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M.

Urol Oncol. 2018 Jul;36(7):341.e9-341.e14. doi: 10.1016/j.urolonc.2018.04.003. Epub 2018 May 3.

PMID:
29730065
44.

Clinical Role of Programmed Cell Death-1 Expression in Patients with Non-muscle-invasive Bladder Cancer Recurring After Initial Bacillus Calmette-Guérin Therapy.

Fukumoto K, Kikuchi E, Mikami S, Hayakawa N, Matsumoto K, Niwa N, Oya M.

Ann Surg Oncol. 2018 Aug;25(8):2484-2491. doi: 10.1245/s10434-018-6498-2. Epub 2018 May 1.

PMID:
29717423
45.

Prognostic Value of Baseline Serum C-Reactive Protein Level in Intermediate-Risk Group Patients With Metastatic Renal-Cell Carcinoma Treated by First-Line Vascular Endothelial Growth Factor-Targeted Therapy.

Takamatsu K, Mizuno R, Omura M, Morita S, Matsumoto K, Shinoda K, Kosaka T, Takeda T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Clin Genitourin Cancer. 2018 Aug;16(4):e927-e933. doi: 10.1016/j.clgc.2018.03.012. Epub 2018 Mar 27.

PMID:
29678472
46.

Change of the 5α/5β ratio of urinary steroid metabolites in benign prostatic hyperplasia patients treated with dutasteride.

Maeda T, Kikuchi E, Hasegawa M, Homma K, Yasumizu Y, Hattori S, Kosaka T, Shinoda K, Miyajima A, Oya M.

Clin Biochem. 2018 May;55:36-41. doi: 10.1016/j.clinbiochem.2018.03.021. Epub 2018 Mar 31.

PMID:
29608891
47.

Incidence and timing of inadvertent nephrostomy catheter displacement in patients with ureteral obstruction
.

Niwa N, Matsumoto K, Kikuchi E, Yazawa S, Takeda T, Morita S, Kosaka T, Shinoda K, Mizuno R, Shinojima T, Asanuma H, Oya M.

Clin Nephrol. 2018 Aug;90(2):112-116. doi: 10.5414/CN109294.

PMID:
29578400
48.

Ancylostoma ceylanicum, novel etiological agent for traveler's diarrhea-report of four Japanese patients who returned from Southeast Asia and Papua New Guinea.

Yoshikawa M, Ouji Y, Hirai N, Nakamura-Uchiyama F, Yamada M, Arizono N, Akamatsu N, Yoh T, Kaya D, Nakatani T, Kikuchi E, Katanami Y, Satoh K, Maki R, Miyazato Y, Oba Y, Kasahara K, Mikasa K.

Trop Med Health. 2018 Mar 13;46:6. doi: 10.1186/s41182-018-0087-8. eCollection 2018.

49.

A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study.

Inoue T, Miyazaki J, Ichioka D, Narita S, Kageyama S, Sugimoto M, Mitsuzuka K, Shiraishi Y, Kinoshita H, Wakeda H, Nomoto T, Kikuchi E, Matsui Y, Fujie K, Habuchi T, Nishiyama H.

BMC Cancer. 2018 Mar 14;18(1):290. doi: 10.1186/s12885-018-4186-z.

50.

Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer.

Kobayashi H, Kosaka T, Mikami S, Miyazaki Y, Matsumoto K, Kikuchi E, Miyajima A, Kameyama K, Sato Y, Oya M.

Oncotarget. 2017 Dec 7;9(12):10203-10210. doi: 10.18632/oncotarget.23011. eCollection 2018 Feb 13.

Supplemental Content

Loading ...
Support Center